S
S. Pauluzzi
Researcher at University of Perugia
Publications - 28
Citations - 1180
S. Pauluzzi is an academic researcher from University of Perugia. The author has contributed to research in topics: Teicoplanin & Cancer. The author has an hindex of 15, co-authored 28 publications receiving 1164 citations.
Papers
More filters
Journal ArticleDOI
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.
Adriana Ammassari,Rita Murri,Patrizio Pezzotti,Maria Paola Trotta,Laura Ravasio,Patrizio De Longis,Sergio Lo Caputo,Pasquale Narciso,S. Pauluzzi,Giampiero Carosi,Salvatore Nappa,P. Piano,Izzo Cm,Miriam Lichtner,Giovanni Rezza,Antonella d'Arminio Monforte,Giuseppe Ippolito,Mauro Moroni,Albert W. Wu,Andrea Antinori +19 more
TL;DR: In addition to patient characteristics, medication‐related variables, and reasons for nonadherence, patient‐reported symptoms and medication side effects were significantly associated with adherence to HAART.
Journal ArticleDOI
Secondary Mutations in the Protease Region of Human Immunodeficiency Virus and Virologic Failure in Drug-Naive Patients Treated with Protease Inhibitor-Based Therapy
Carlo Federico Perno,Alessandro Cozzi-Lepri,Claudia Balotta,Federica Forbici,Michela Violin,Ada Bertoli,Guido Facchi,Patrizio Pezzotti,Gianpiero Cadeo,Giulio Tositti,Sandro Pasquinucci,S. Pauluzzi,Alfredo Scalzini,B. Salassa,Antonella Vincenti,Andrew N. Phillips,Ferdinando Dianzani,A. Appice,Gioacchino Angarano,Laura Monno,Giuseppe Ippolito,Mauro Moroni,Antonella d'Arminio Monforte +22 more
TL;DR: The role of mutations in protease (PR) and reverse-transcriptase (RT) of human immunodeficiency virus (HIV) in predicting virologic failure was assessed in 248 antiretroviral-naive HIV-positive patients who began a PR inhibitor-containing antirrhine regimen as discussed by the authors.
Journal ArticleDOI
High-Dose Fluconazole Therapy for Cryptococcal Meningitis in Patients with AIDS
Francesco Menichetti,Maurizio Fiorio,Andrea Tosti,Giorgio Gatti,Maria Bruna Pasticci,Franca Miletich,Massimo Marroni,Dante Bassetti,S. Pauluzzi +8 more
TL;DR: High-dose fluconazole might be an effective and well-tolerated therapeutic option for patients with AIDS and acute cryptococcal meningitis.
Journal ArticleDOI
Unusual Presentation of Life-Threatening Toscana Virus Meningoencephalitis
Franco Baldelli,Maria Grazia Ciufolini,Daniela Francisci,Antonella Marchi,Giulietta Venturi,Cristiano Fiorentini,Maria Laura Luchetta,Lidia Bruto,S. Pauluzzi +8 more
TL;DR: This case report describes a brother and a sister with severe meningoencephalitis caused by Toscana virus (TOSv), characterized by stiff neck, deep coma, maculopapular rash, diffuse lymphadenopathy, hepatosplenomegaly, renal involvement, tendency to bleeding, and diffuse intravascular coagulation.
Journal ArticleDOI
Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.
A. Del Favero,Francesco Menichetti,R. Guerciolini,Giampaolo Bucaneve,Franco Baldelli,Franco Aversa,Adelmo Terenzi,Stephen Davis,S. Pauluzzi +8 more
TL;DR: Teicoplanin, as a drug administered as a single daily dose, seems to be a safe and useful anti-gram-positive agent when used in combination with amikacin-ceftazidime as an empiric therapy of febrile episodes in granulocytopenic acute leukemia patients.